Tuesday, April 30, 2019

Zydus Cadila gets USFDA nod to market 2 generic drugs

Zydus Cadila gets USFDA nod to market 2 generic drugs The company has received final approval from the US heath regulator to market Bosentan tablets USP in strengths of 62.5 mg and 125 mg and Trientine Hydrochloride capsules USP in the strength of 250 mg, Zydus Cadila said in a statement.

from Moneycontrol Business News http://bit.ly/2PFMbX8
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...